PUBLISHED DATE : Jun 2023 | Pages : 248
Fill out your details & get your free sample
The U.S. Remote Patient Monitoring Market Size, Share, & Trends Analysis Report By
Industry Analysis Report, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast, 2023–2028
248 Pages
70 Tables
86 Charts
4 Regions
1 Countries
48 Companies
4 Market Segment
| Report Attribute | Details |
|---|---|
| Market Size (2028) | USD 25.28 Billion |
| Market Size (2022) | USD 13.40 Billion |
| CAGR (2022-2028) | 11.16% |
| Base Year | 2022 |
| Forecast Year | 2023-2028 |
| Market Segments | Component, Application, End-User, and Geography |
| Geographic Analysis | United States (South, West, Midwest, and Northeast) |
| KEY VENDORS | AMD Global Telemedicine, GE Healthcare, Koninklijke Philips, Medtronic, ResMed, Teledoc Health, and Vivify Health |
MARKET OUTLOOK
The U.S. remote patient monitoring market was valued at USD 13.40 billion in 2022 and is expected to reach USD 25.28 billion by 2028, growing at a CAGR of 11.16%. Healthcare delivery through electronic communication and telehealth has significantly changed since its inception. The advent of electronic health records (EHRs) and increased access to the internet and medical devices has enabled healthcare to move from the traditional clinical setting to the patient's home. Remote patient monitoring (RPM) is a type of telehealth in which healthcare providers monitor patients outside of traditional care using digital medical devices such as scales, blood pressure monitors, pulse oximeters, and blood glucose meters. Data collected from these devices is sent electronically to care management providers. Automated feedback and workflows can be incorporated into data collection to flag out-of-range or critical readings. Further, the increasing prevalence of chronic diseases, technological advancements, and higher penetration of mHealth are some of the key drivers of the U.S. remote patient monitoring market growth.
During the COVID-19 public health emergency (PHE), telehealth replaced face-to-face consultations with virtual processes wherever possible, exposing patients to infected patients. Like other forms of telehealth, RPM implementations have grown and evolved rapidly throughout PHE. In addition to increasing the use of RPM for chronic illnesses, many organizations have begun acute illness surveillance and developing programs to monitor patients for COVID-19 symptoms outside hospitals. These programs aimed to reduce hospital burden and identify changes in patient conditions during increased hospital occupancy. Moreover, healthcare systems are partnering with market vendors and other key stakeholders to increase awareness of the advantages of remote patient monitoring devices, thereby contributing to U.S. remote patient monitoring market growth. Key players in the market are focused on product approval and launch to expand their product portfolio, contributing to technological advancements and catering to consumers who constantly demand these monitoring devices.
Advances in Remote Patient Monitoring Technology
The COVID-19 pandemic has accelerated the growth of the U.S. remote patient monitoring market and has caught the attention of many medical professionals. Recently, IoT-enabled monitoring devices have added offering more functionalities to RPM. By combining AI with the Internet of Things (IoT) and RPM, healthcare organizations and practitioners can better serve their patients and provide opportunities for improved healthcare outcomes.
Increasing Demand for Wireless Patient Monitoring at Home
Over the last few years, home patient monitoring has become a standard of care among adult patients that require a long-term alternative to hospital-based care. The trend toward using a wireless patient monitoring system to monitor vital signs continues to grow. Among many benefits being brought to the healthcare service by wireless patient monitoring is the facility to escalate home care for both chronic and acute conditions. The emergence of new technologies and capabilities makes taking care of one at home possible.
Increasing Focus on Developing Software & Apps for RPM by Manufacturers
Increasing focus on developing software and apps specifically for remote patient monitoring (RPM) by manufacturers is an innovative way to improve and simplify the management of health conditions in both private and public healthcare settings. This ensures that care providers have access to accurate and secure data collected from patients tracked remotely through wearables and connected devices. Manufacturers in the U.S. remote patient monitoring market are investing in this trend by creating apps and software solutions that offer customizable and secure data-driven solutions for RPM. These solutions range from automated patient feedback protocols to machine learning algorithms that better track patient data and behavior. Manufacturers are also offering user-friendly and secure ways for care providers to access more accurate patient data and make informed decisions based on the data. This is creating a new landscape of both secure and efficient RPM services.
The Growing Use of RPM to Monitor & Improve Patient Engagement
Remote patient monitoring (RPM) uses technology to collect, transmit, and review patient-generated data outside the traditional medical care setting. It allows healthcare providers to remotely monitor patients and gain insight into their physical state without having them physically present for a physical check-up. RPM can also detect changes in a patient's condition before they become obvious to the patient and help healthcare providers provide better, more personalized, and timely care. Through RPM, healthcare providers can keep track of patients' medical conditions in real time and monitor them from a distance. It enables clinicians to identify potentially serious illnesses early and intervene with appropriate treatment. RPM can lead to better outcomes, improved patient engagement, and fewer hospitalizations. RPM also reduces healthcare costs by providing earlier treatment and better managing chronic conditions. Patients benefit from quality care while remaining in their homes with improved access to care and an enhanced overall care experience.
Miniaturization is the next big thing in RPM devices using advanced technology. Device key players are reducing the size and invasiveness of their products while cooperating with new companies to boost their share in the U.S. remote patient monitoring market.
Growing Use of Mobile Technologies & Smart Devices in RPM
Remote patient monitoring uses smartphones, tablets, and other devices to track patient health information constantly. It enables healthcare providers to track a wide range of vital signs such as heart rate, blood pressure, respiratory rate, and body temperature, allowing them to monitor patients from the comfort of their homes. With the growing use of mobile technology, remote patient monitoring can be done on the go. This improves access to care for remote populations and increases efficiency in healthcare delivery. Additionally, it enables real-time remote monitoring of those with chronic illnesses, allowing for timely intervention to prevent further health complications. Mobile technology also ensures data accuracy and consistency, critical for effective decision-making and patient care.
INSIGHTS BY COMPONENT
The U.S. remote patient monitoring market by component is segmented into services and, devices & software. In 2022, the software segment accounted for the largest share of the market. Service in the remote patient monitoring market involves using telemetric technology to monitor and collect patient health data from a remote location. This technology allows medical professionals to monitor their patient's health without requiring them to enter a physical medical facility. These services provide access to real-time patient health data, such as blood pressure, blood glucose levels, body temperature, and heart rate. In addition, telemetry technology can also be used to send alerts if an unusual change in vital signs is detected, allowing medical professionals to intervene quickly. This technology allows medical professionals to provide the best care for patients while they are away from the hospital and allows for earlier interventions when needed.
INSIGHTS BY APPLICATION
The cardiovascular diseases application segment held the largest U.S. remote patient monitoring market share in 2022, accounting for over 39%. According to the Centers for Disease Control and Prevention (CDC), approximately 11 million patients in the US suffer from cardiac dysrhythmia or arrhythmias. An increase in the prevalence of cardiovascular diseases (CVDs) is one of the factors driving the demand for cardiac monitoring devices. Remote cardiac monitoring has become the norm for patients with heart diseases, especially using implantable cardiac devices. With easy access to real-time telemetry data, cardiologists can determine if a condition represents an emergency illness and create an essentially virtual hospital. In addition, a quarter of health agencies report that RPM reduces visits and readmissions to emergency rooms. Further, the increased use of remote cardiac monitors to improve the detection of hypertension has been the focus of intense research activity in recent years. Remote cardiac monitors provide a viable solution for detecting hypertension at home without cumbersome and intrusive devices and procedures.
INSIGHTS BY END-USER
The U.S. remote patient monitoring market by end-user is segmented into hospitals, home healthcare settings, ambulatory care settings, and long-term care centers. The hospital's segment accounted for the largest share and dominated the segment. The U.S. healthcare system and hospitals plan to improve outcomes and reduce costs through remote patient monitoring (RPM) technology. Hospital settings dominate cardiac monitoring equipment and are the initial point of contact for patients with health challenges. Patients with a history of cardiac arrhythmia are typically treated in hospitals. For the monitoring of CVDs, hospitals have the most up-to-date machines and technology. Though healthcare practitioners are always looking for ways to reduce patients' time in the hospital, the COVID-19 epidemic has increased pressure on physicians to minimize contact time even more to avoid virus exposure. One method that healthcare practitioners are addressing this issue is through remote patient monitoring. By allowing doctors to monitor their patients outside the hospital or doctor's office, they can reduce patients' time in those settings without jeopardizing their health.
The southern region accounted for 41% of the U.S. remote patient monitoring market in 2022 and dominated the market. The use of remote patient monitoring in Texas has steadily increased over the past few years. This technology is now being implemented in healthcare organizations across the state to help monitor, manage, and provide patient care more efficiently and effectively. The emergence of remote patient monitoring technology and its steady increase in usage in Texas reflects the state's commitment to providing improved patient care. Remote patient monitoring has been instrumental in cutting costs, as it allows for fewer hospital and clinic visits, thus decreasing the likelihood of patient complications due to prolonged exposure and wait times in an unfamiliar setting.
The remote patient monitoring market in the western U.S. and states like California is fast-growing and evolving. As the nation's largest and most populous state, the opportunities for meaningful collaboration on remote care through digital health tools are virtually limitless. Remote health monitoring or telehealth is a rapidly-expanding healthcare segment, allowing clinicians, care providers, and other health professionals to connect with and monitor patient populations remotely.
The U.S. remote patient monitoring market is in a state of intense competition. The industry includes providers of a range of products and services, from diagnosis and treatment to delivery of healthcare applications. Companies operating in this segment are continually forced to innovate and improve to gain a competitive edge. Over the past few years, the U.S. remote patient monitoring market has grown rapidly with the entry of new players and the widespread adoption of technological advances. The focus is shifting towards conquering and expanding the market share from smaller, more localized players to larger, national-scale players. This competition has led to market size, scope growth, and product diversification.
AMD Global Telemedicine, GE Healthcare, Koninklijke Philips, Medtronic, ResMed, Teledoc Health, and Vivify Health are some of the top vendors in the U.S. remote patient monitoring market, offering a wide range of RPM solutions. However, many local vendors are providing products with similar specifications at lower prices, which has resulted in a price war among vendors. Major vendors continuously compete for the leading position in the market, with occasional competition coming from other local vendors.
Frequently Asked Questions
How big is the U.S. remote patient monitoring market?
The U.S. remote patient monitoring market size was valued at USD 13.40 billion in 2022 and is expected to reach USD 25.28 billion by 2028.
What is the growth rate of the U.S. remote patient monitoring market?
The U.S. remote patient monitoring market is growing at a CAGR of 11.16% from 2022-2028.
What are the rising trends in the U.S. remote patient monitoring market?
The rising trends in the US remote patient monitoring market are advances in remote patient monitoring technology, increasing demand for wireless patient monitoring at home, the rise of virtual clinical trials, AI & IoT driving the adoption of remote patient monitoring, and telemedicine ushering new opportunities for remote monitoring.
Which region holds the most significant U.S. remote patient monitoring market share?
The south region dominated the global U.S. remote patient monitoring market share in 2022, accounting for over 41.%.
Who are the top players in the U.S. remote patient monitoring market?
AMD Global Telemedicine, GE Healthcare, Koninklijke Philips, Medtronic, ResMed, Teledoc Health, and Vivify Health are the top players in the U.S. remote patient monitoring market.
The U.S. remote patient monitoring market is expected to grow at a CAGR of approximately 11.16% from 2022 to 2028.
The following factors are likely to contribute to the growth of the U.S. remote patient monitoring market during the forecast period:
Base Year: 2022
Forecast Year: 2023-2028
The report considers the present scenario of the U.S. remote patient monitoring market and its market dynamics for 2023−2028. It covers a detailed overview of several market growth enablers, restraints, and trends. The study covers both the demand and supply sides of the industry. It also profiles and analyzes leading companies and several other prominent companies operating in the industry.
Key Company Profiles
Other Prominent Vendors
Segmentation by Component
Segmentation by Application
Segmentation by End-User
Segmentation by Region
1 RESEARCH METHODOLOGY
2 RESEARCH OBJECTIVES
3 RESEARCH PROCESS
4 SCOPE & COVERAGE
4.1 MARKET DEFINITION
4.1.1 INCLUSIONS
4.1.2 EXCLUSIONS
4.1.3 MARKET ESTIMATION CAVEATS
4.2 BASE YEAR
4.3 SCOPE OF THE STUDY
4.3.1 MARKET SEGMENTATION BY COMPONENT
4.3.2 MARKET SEGMENTATION BY APPLICATION
4.3.3 MARKET SEGMENTATION BY END-USER
4.3.4 MARKET SEGMENTATION BY GEOGRAPHY
5 REPORT ASSUMPTIONS & CAVEATS
5.1 KEY CAVEATS
5.2 CURRENCY CONVERSION
5.3 MARKET DERIVATION
6 MARKET AT A GLANCE
7 PREMIUM INSIGHTS
7.1 OVERVIEW
7.1.1 COMPONENT INSIGHTS
7.1.2 APPLICATION INSIGHTS
7.1.3 END-USER INSIGHTS
8 INTRODUCTION
8.1 BACKGROUND
8.2 REMOTE PATIENT MONITORING: OVERVIEW
8.3 REMOTE PATIENT MONITORING: GLOBAL OUTLOOK
8.3.1 GLOBAL REMOTE PATIENT MONITORING BY GEOGRAPHY
8.4 REMOTE PATIENT MONITORING: GLOBAL VS US OUTLOOK
9 MARKET OPPORTUNITIES & TRENDS
9.1 ADVANCES IN REMOTE PATIENT MONITORING TECHNOLOGY
9.2 INCREASING DEMAND FOR WIRELESS PATIENT MONITORING AT HOME
9.3 RISE OF VIRTUAL CLINICAL TRIALS
9.4 AI & IOT DRIVES RPM ADOPTION
9.5 TELEMEDICINE USHERING NEW OPPORTUNITIES FOR REMOTE MONITORING
10 MARKET GROWTH ENABLERS
10.1 INCREASING FOCUS ON DEVELOPING SOFTWARE & APPS FOR RPM BY MANUFACTURERS
10.2 AGING POPULATION & CHRONIC DISORDERS AUGMENTING CONTINUOUS MONITORING DEMAND
10.3 INCREASING INNOVATIONS IN WEARABLE TECHNOLOGY
10.4 GROWING USE OF RPM TO MONITOR & IMPROVE PATIENT ENGAGEMENT
10.5 GROWING USE OF MOBILE TECHNOLOGIES & SMART DEVICES IN RPM
11 MARKET RESTRAINTS
11.1 REGULATORY VARIATIONS ACROSS US
11.2 LACK OF DATA ACCURACY
11.3 THREAT FROM HEALTHCARE FRAUDS
11.4 ACCESSIBILITY OR CONNECTIVITY OBSTACLES WITH PATIENTS
12 MARKET LANDSCAPE
12.1 MARKET OVERVIEW
12.2 MARKET SIZE & FORECAST
12.3 MARKET OPPORTUNITIES
12.3.1 MARKET BY COMPONENT
12.3.2 MARKET BY APPLICATION
12.3.3 MARKET BY END-USER
12.4 FIVE FORCES ANALYSIS
12.4.1 THREAT OF NEW ENTRANTS
12.4.2 BARGAINING POWER OF SUPPLIERS
12.4.3 BARGAINING POWER OF BUYERS
12.4.4 THREAT OF SUBSTITUTES
12.4.5 COMPETITIVE RIVALRY
13 COMPONENT
13.1 MARKET SNAPSHOT & GROWTH ENGINE
13.2 MARKET OVERVIEW
13.3 SERVICES
13.3.1 MARKET OVERVIEW
13.3.2 MARKET SIZE & FORECAST
13.4 DEVICES & SOFTWARE
13.4.1 MARKET OVERVIEW
13.4.2 MARKET SIZE & FORECAST
14 APPLICATION
14.1 MARKET SNAPSHOT & GROWTH ENGINE
14.2 MARKET OVERVIEW
14.3 CARDIOVASCULAR DISEASES
14.3.1 MARKET OVERVIEW
14.3.2 MARKET SIZE & FORECAST
14.4 RESPIRATORY DISEASES
14.4.1 MARKET OVERVIEW
14.4.2 MARKET SIZE & FORECAST
14.5 DIABETES
14.5.1 MARKET OVERVIEW
14.5.2 MARKET SIZE & FORECAST
14.6 MUSCULOSKELETAL DISEASES
14.6.1 MARKET OVERVIEW
14.6.2 MARKET SIZE & FORECAST
14.7 OTHERS
14.7.1 MARKET OVERVIEW
14.7.2 MARKET SIZE & FORECAST
15 END-USER
15.1 MARKET SNAPSHOT & GROWTH ENGINE
15.2 MARKET OVERVIEW
15.3 HOSPITALS
15.3.1 MARKET OVERVIEW
15.3.2 MARKET SIZE & FORECAST
15.4 HOME HEALTHCARE SETTINGS
15.4.1 MARKET OVERVIEW
15.4.2 MARKET SIZE & FORECAST
15.5 AMBULATORY SURGICAL CENTERS
15.5.1 MARKET OVERVIEW
15.5.2 MARKET SIZE & FORECAST
15.6 LONG-TERM CARE CENTERS
15.6.1 MARKET OVERVIEW
15.6.2 MARKET SIZE & FORECAST
16 COMPETITIVE LANDSCAPE
16.1 COMPETITION OVERVIEW
16.1.1 VENDORS ACTIVITIES
16.2 MARKET SHARE ANALYSIS
16.2.1 AMD GLOBAL TELEMEDICINE
16.2.2 GE HEALTHCARE
16.2.3 KONINKLIJKE PHILIPS
16.2.4 MEDTRONIC
16.2.5 RESMED
16.2.6 TELADOC HEALTH
16.2.7 VIVIFY HEALTH
17 KEY COMPANY PROFILES
17.1 AMD GLOBAL TELEMEDICINE
17.1.1 BUSINESS OVERVIEW
17.1.2 PRODUCT OFFERINGS
17.1.3 KEY STRATEGIES
17.1.4 KEY STRENGTHS
17.1.5 KEY OPPORTUNITIES
17.2 GE HEALTHCARE
17.2.1 BUSINESS OVERVIEW
17.2.2 PRODUCT OFFERINGS
17.2.3 KEY STRATEGIES
17.2.4 KEY STRENGTHS
17.2.5 KEY OPPORTUNITIES
17.3 KONINKLIJKE PHILIPS
17.3.1 BUSINESS OVERVIEW
17.3.2 PRODUCT OFFERINGS
17.3.3 KEY STRATEGIES
17.3.4 KEY STRENGTHS
17.3.5 KEY OPPORTUNITIES
17.4 MEDTRONIC
17.4.1 BUSINESS OVERVIEW
17.4.2 PRODUCT OFFERINGS
17.4.3 KEY STRATEGIES
17.4.4 KEY STRENGTHS
17.4.5 KEY OPPORTUNITIES
17.5 RESMED
17.5.1 BUSINESS OVERVIEW
17.5.2 PRODUCT OFFERING
17.5.3 KEY STRATEGIES
17.5.4 KEY STRENGTHS
17.5.5 KEY OPPORTUNITIES
17.6 TELADOC HEALTH
17.6.1 BUSINESS OVERVIEW
17.6.2 PRODUCT OFFERINGS
17.6.3 KEY STRATEGIES
17.6.4 KEY STRENGTHS
17.6.5 KEY OPPORTUNITIES
17.7 VIVIFY HEALTH
17.7.1 BUSINESS OVERVIEW
17.7.2 PRODUCT OFFERING
17.7.3 KEY STRATEGIES
17.7.4 KEY STRENGTHS
17.7.5 KEY OPPORTUNITIES
18 OTHER PROMINENT VENDORS
18.1 100-PLUS
18.1.1 BUSINESS OVERVIEW
18.1.2 PRODUCT OFFERINGS
18.2 ABBOTT
18.2.1 BUSINESS OVERVIEW
18.2.2 PRODUCT OFFERINGS
18.3 ACL DIGITAL
18.3.1 BUSINESS OVERVIEW
18.3.2 PRODUCT OFFERINGS
18.4 ALTUMVIEW
18.4.1 BUSINESS OVERVIEW
18.4.2 PRODUCT OFFERINGS
18.5 BAXTER
18.5.1 BUSINESS OVERVIEW
18.5.2 PRODUCT OFFERINGS
18.6 BIOBEAT
18.6.1 BUSINESS OVERVIEW
18.6.2 PRODUCT OFFERINGS
18.7 BIOFOURMIS
18.7.1 BUSINESS OVERVIEW
18.7.2 PRODUCT OFFERING
18.8 BIOTRONIK
18.8.1 BUSINESS OVERVIEW
18.8.2 PRODUCT OFFERING
18.9 BOSTON SCIENTIFIC
18.9.1 BUSINESS OVERVIEW
18.9.2 PRODUCT OFFERINGS
18.10 CARDIOLOGS
18.10.1 BUSINESS OVERVIEW
18.10.2 PRODUCT OFFERINGS
18.11 CARDIOMO
18.11.1 BUSINESS OVERVIEW
18.11.2 PRODUCT OFFERINGS
18.12 CAREMINDR
18.12.1 BUSINESS OVERVIEW
18.12.2 PRODUCT OFFERING
18.13 CAREVALIDATE
18.13.1 BUSINESS OVERVIEW
18.13.2 PRODUCT OFFERINGS
18.14 CLEARARCH
18.14.1 BUSINESS OVERVIEW
18.14.2 PRODUCT OFFERINGS
18.15 DATOS HEALTH
18.15.1 BUSINESS OVERVIEW
18.15.2 PRODUCT OFFERINGS
18.16 DEXCOM
18.16.1 BUSINESS OVERVIEW
18.16.2 PRODUCT OFFERING
18.17 DRÄGERWERK AG
18.17.1 BUSINESS OVERVIEW
18.17.2 PRODUCT OFFERINGS
18.18 F. HOFFMANN-LA ROCHE
18.18.1 BUSINESS OVERVIEW
18.18.2 PRODUCT OFFERINGS
18.19 GRANDCARE SYSTEMS
18.19.1 BUSINESS OVERVIEW
18.19.2 PRODUCT OFFERINGS
18.20 HEALTH RECOVERY SOLUTIONS
18.20.1 BUSINESS OVERVIEW
18.20.2 PRODUCT OFFERINGS
18.21 HINGE HEALTH
18.21.1 BUSINESS OVERVIEW
18.21.2 PRODUCT OFFERINGS
18.22 HONEYWELL INTERNATIONAL
18.22.1 BUSINESS OVERVIEW
18.22.2 PRODUCT OFFERINGS
18.23 IHEALTH UNIFIED CARE
18.23.1 BUSINESS OVERVIEW
18.23.2 PRODUCT OFFERINGS
18.24 INTEL
18.24.1 BUSINESS OVERVIEW
18.24.2 PRODUCT OFFERING
18.25 IRHYTHM TECHNOLOGIES
18.25.1 BUSINESS OVERVIEW
18.25.2 PRODUCT OFFERING
18.26 LIMBER HEALTH
18.26.1 BUSINESS OVERVIEW
18.26.2 PRODUCT OFFERINGS
18.27 MASIMO
18.27.1 BUSINESS OVERVIEW
18.27.2 PRODUCT OFFERINGS
18.28 MEDM
18.28.1 BUSINESS OVERVIEW
18.28.2 PRODUCT OFFERING
18.29 MEDOPAD
18.29.1 BUSINESS OVERVIEW
18.29.2 PRODUCT OFFERINGS
18.30 MODIVCARE
18.30.1 BUSINESS OVERVIEW
18.30.2 PRODUCT OFFERINGS
18.31 NIHON KOHDEN
18.31.1 BUSINESS OVERVIEW
18.31.2 PRODUCT OFFERINGS
18.32 OMRON
18.32.1 BUSINESS OVERVIEW
18.32.2 PRODUCT OFFERINGS
18.33 OSI SYSTEMS
18.33.1 BUSINESS OVERVIEW
18.33.2 PRODUCT OFFERINGS
18.34 OSPLABS
18.34.1 BUSINESS OVERVIEW
18.34.2 PRODUCT OFFERINGS
18.35 QARDIO
18.35.1 BUSINESS OVERVIEW
18.35.2 PRODUCT OFFERING
18.36 SENSEONICS
18.36.1 BUSINESS OVERVIEW
18.36.2 PRODUCT OFFERINGS
18.37 TELEMEDCARE
18.37.1 BUSINESS OVERVIEW
18.37.2 PRODUCT OFFERINGS
18.38 VENTRICLE HEALTH
18.38.1 BUSINESS OVERVIEW
18.38.2 PRODUCT OFFERINGS
18.39 VITALCONNECT
18.39.1 PRODUCT OFFERINGS
18.40 VITLS
18.40.1 BUSINESS OVERVIEW
18.40.2 PRODUCT OFFERINGS
18.41 VIVALNK
18.41.1 BUSINESS OVERVIEW
18.41.2 PRODUCT OFFERINGS
19 REPORT SUMMARY
19.1 KEY TAKEAWAYS
19.2 STRATEGIC RECOMMENDATIONS
20 QUANTITATIVE SUMMARY
20.1 MARKET BY COMPONENT
20.2 MARKET BY APPLICATION
20.3 MARKET BY END-USER
20.4 HOME HEALTHCARE SETTINGS BY REGION
20.5 HOME HEALTHCARE SETTINGS BY COMPONENT
20.6 HOME HEALTHCARE SETTINGS BY APPLICATION
21 APPENDIX
21.1 ABBREVIATIONS
EXHIBIT 1 SEGMENTATION OF US REMOTE PATIENT MONITORING MARKET
EXHIBIT 2 MARKET SIZE CALCULATION APPROACH 2022
EXHIBIT 3 US REMOTE PATIENT MONITORING MARKET BY COMPONENT 2022 & 2028 (% SHARE)
EXHIBIT 4 US REMOTE PATIENT MONITORING MARKET BY APPLICATION 2022 & 2028 (% SHARE)
EXHIBIT 5 US REMOTE PATIENT MONITORING MARKET BY END-USER 2022 & 2028 (% SHARE)
EXHIBIT 6 COMPONENTS OF TELEHEALTH SERVICES
EXHIBIT 7 HEALTHCARE IOT & RPM TRANSFORMING CARE DELIVERY
EXHIBIT 8 GLOBAL REMOTE PATIENT MONITORING MARKET 2022–2028 ($ BILLION)
EXHIBIT 9 GLOBAL REMOTE PATIENT MONITORING MARKET BY GEOGRAPHY: 2022 & 2028 (% SHARE)
EXHIBIT 10 REMOTE PATIENT MONITORING MARKET SHARE: US & REST OF WORLD (% SHARE)
EXHIBIT 11 CONSUMER RESPONSE TOWARD REMOTE PATIENT MONITORING ADOPTION IN US
EXHIBIT 12 NEW CPT CODES REIMBURSE FOR REMOTE PATIENT MONITORING
EXHIBIT 13 IMPACT OF ADVANCES IN REMOTE PATIENT MONITORING TECHNOLOGY
EXHIBIT 14 IMPACT OF INCREASING DEMAND FOR WIRELESS PATIENT MONITORING AT HOME
EXHIBIT 15 IMPACT OF RISE OF VIRTUAL CLINICAL TRIALS
EXHIBIT 16 POTENTIAL FACTORS DRIVING VIRTUAL CLINICAL TRIALS IN US
EXHIBIT 17 PATIENT MONITORING EXAMPLES: OVERVIEW OF WEARABLE AND DEVICE INTEGRATION IN DCTS
EXHIBIT 18 NEW CONNECTED DEVICES POWERS CLINICAL TRIALS WITH BETTER DATA
EXHIBIT 19 IMPACT OF AI & IOT DRIVES RPM ADOPTION
EXHIBIT 20 IMPACT OF TELEMEDICINE USHERING NEW OPPORTUNITIES FOR REMOTE MONITORING
EXHIBIT 21 IMPACT OF INCREASING FOCUS ON DEVELOPING SOFTWARE & APPS FOR RPM BY MANUFACTURERS
EXHIBIT 22 IMPACT OF AGING POPULATION & CHRONIC DISORDERS AUGMENTING CONTINUOUS MONITORING DEMAND
EXHIBIT 23 PREVALENCE DATA OF CHRONIC DISEASES IN THE US
EXHIBIT 24 IMPACT OF INCREASING INNOVATIONS IN WEARABLE TECHNOLOGY
EXHIBIT 25 CONVERGENCE OF TECHNOLOGIES LEADING TO THE INDUSTRIAL REVOLUTION
EXHIBIT 26 ADVANTAGES OF USING REMOTE BIOSENSORS IN CLINICAL RESEARCH
EXHIBIT 27 IMPACT OF GROWING USE OF RPM TO MONITOR & IMPROVE PATIENT ENGAGEMENT
EXHIBIT 28 WAYS REMOTE PATIENT MONITORING IMPROVES PATIENT ENGAGEMENT
EXHIBIT 29 IMPACT OF GROWING USE OF MOBILE TECHNOLOGIES & SMART DEVICES IN RPM
EXHIBIT 30 IMPACT OF REGULATORY VARIATIONS ACROSS US
EXHIBIT 31 IMPACT OF LACK OF DATA ACCURACY
EXHIBIT 32 IMPACT OF THREAT FROM HEALTHCARE FRAUDS
EXHIBIT 33 IMPACT OF ACCESSIBILITY OR CONNECTIVITY OBSTACLES WITH PATIENTS
EXHIBIT 34 US REMOTE PATIENT MONITORING MARKET 2022–2028 ($ BILLION)
EXHIBIT 35 US REMOTE PATIENT MONITORING MARKET BY COMPONENT: MARKET OPPORTUNITY OVERVIEW 2022 & 2028
EXHIBIT 36 US REMOTE PATIENT MONITORING MARKET BY APPLICATION: MARKET OPPORTUNITY OVERVIEW 2022 & 2028
EXHIBIT 37 US REMOTE PATIENT MONITORING MARKET BY END-USER: MARKET OPPORTUNITY OVERVIEW 2022 & 2028
EXHIBIT 38 FIVE FORCES ANALYSIS 2022
EXHIBIT 39 INCREMENTAL GROWTH BY COMPONENT 2022 & 2028
EXHIBIT 40 US REMOTE PATIENT MONITORING MARKET BY COMPONENT: INCREMENTAL GROWTH
EXHIBIT 41 US REMOTE PATIENT MONITORING MARKET BY COMPONENT: ABSOLUTE GROWTH
EXHIBIT 42 US SERVICES REMOTE PATIENT MONITORING MARKET: INCREMENTAL & ABSOLUTE GROWTH 2022–2028
EXHIBIT 43 US SERVICES REMOTE PATIENT MONITORING MARKET 2022–2028 ($ BILLION)
EXHIBIT 44 US DEVICES & SOFTWARE REMOTE PATIENT MONITORING MARKET: INCREMENTAL & ABSOLUTE GROWTH 2022–2028
EXHIBIT 45 US DEVICES & SOFTWARE REMOTE PATIENT MONITORING MARKET 2022–2028 ($ BILLION)
EXHIBIT 46 INCREMENTAL GROWTH BY APPLICATION 2022 & 2028
EXHIBIT 47 US REMOTE PATIENT MONITORING MARKET BY APPLICATION: INCREMENTAL GROWTH
EXHIBIT 48 PREVALENCE OF CHRONIC CONDITIONS AND THEIR EXPONENTIAL IMPACT ON HEALTHCARE COSTS IN US
EXHIBIT 49 US REMOTE PATIENT MONITORING MARKET BY APPLICATION: ABSOLUTE GROWTH
EXHIBIT 50 US CARDIOVASCULAR DISEASES REMOTE PATIENT MONITORING MARKET: INCREMENTAL & ABSOLUTE GROWTH 2022–2028
EXHIBIT 51 US CARDIOVASCULAR DISEASES REMOTE PATIENT MONITORING MARKET 2022–2028 ($ BILLION)
EXHIBIT 52 US RESPIRATORY DISEASES REMOTE PATIENT MONITORING MARKET: INCREMENTAL & ABSOLUTE GROWTH 2022–2028
EXHIBIT 53 US RESPIRATORY DISEASES REMOTE PATIENT MONITORING MARKET 2022–2028 ($ BILLION)
EXHIBIT 54 US DIABETES REMOTE PATIENT MONITORING MARKET: INCREMENTAL & ABSOLUTE GROWTH 2022–2028
EXHIBIT 55 US DIABETES REMOTE PATIENT MONITORING MARKET 2022–2028 ($ BILLION)
EXHIBIT 56 US MUSCULOSKELETAL DISEASES REMOTE PATIENT MONITORING MARKET: INCREMENTAL & ABSOLUTE GROWTH 2022–2028
EXHIBIT 57 US MUSCULOSKELETAL DISEASES REMOTE PATIENT MONITORING MARKET 2022–2028 ($ BILLION)
EXHIBIT 58 US OTHERS REMOTE PATIENT MONITORING MARKET: INCREMENTAL & ABSOLUTE GROWTH 2022–2028
EXHIBIT 59 US OTHERS REMOTE PATIENT MONITORING MARKET 2022–2028 ($ BILLION)
EXHIBIT 60 INCREMENTAL GROWTH BY END-USER 2022 & 2028
EXHIBIT 61 US REMOTE PATIENT MONITORING MARKET BY END-USER: INCREMENTAL GROWTH
EXHIBIT 62 US REMOTE PATIENT MONITORING MARKET BY END-USER: ABSOLUTE GROWTH
EXHIBIT 63 US HOSPITALS REMOTE PATIENT MONITORING MARKET: INCREMENTAL & ABSOLUTE GROWTH 2022–2028
EXHIBIT 64 US HOSPITALS REMOTE PATIENT MONITORING MARKET 2022–2028 ($ BILLION)
EXHIBIT 65 US HOME HEALTHCARE SETTINGS REMOTE PATIENT MONITORING MARKET: INCREMENTAL & ABSOLUTE GROWTH 2022–2028
EXHIBIT 66 US HOME HEALTHCARE SETTINGS REMOTE PATIENT MONITORING MARKET 2022–2028 ($ BILLION)
EXHIBIT 67 US AMBULATORY CARE SETTINGS REMOTE PATIENT MONITORING MARKET: INCREMENTAL & ABSOLUTE GROWTH 2022–2028
EXHIBIT 68 US AMBULATORY CARE SETTINGS REMOTE PATIENT MONITORING MARKET 2022–2028 ($ BILLION)
EXHIBIT 69 US LONG-TERM CARE CENTERS REMOTE PATIENT MONITORING MARKET: INCREMENTAL & ABSOLUTE GROWTH 2022–2028
EXHIBIT 70 US LONG-TERM CARE CENTERS REMOTE PATIENT MONITORING MARKET 2022–2028 ($ BILLION)
EXHIBIT 71 VENDORS OFFERING COMMERCIAL REMOTE PATIENT MONITORING SOLUTIONS: MARKET DOMINANCE ANALYSIS
EXHIBIT 72 VENDORS OFFERING COMMERCIAL REMOTE PATIENT MONITORING SOLUTIONS: CAPABILITIES & EXPERTISE ASSESSMENT
EXHIBIT 73 GE HEALTHCARE: TOTAL REVENUE 2020–2022 ($ BILLION)
EXHIBIT 74 GE HEALTHCARE: REVENUE BY BUSINESS SEGMENT 2022 ($ BILLION)
EXHIBIT 75 KONINKLIJKE PHILIPS: TOTAL REVENUE 2020–2022 ($ BILLION)
EXHIBIT 76 KONINKLIJKE PHILIPS: R&D EXPENDITURE 2020–2022 ($ BILLION)
EXHIBIT 77 KONINKLIJKE PHILIPS: REVENUE BY BUSINESS SEGMENT 2022 ($ BILLION)
EXHIBIT 78 KONINKLIJKE PHILIPS: REVENUE BY GEOGRAPHY 2022 ($ BILLION)
EXHIBIT 79 MEDTRONIC: REVENUE 2020–2022 ($ BILLION)
EXHIBIT 80 MEDTRONIC: R&D EXPENDITURE 2020–2022 ($ BILLION)
EXHIBIT 81 MEDTRONIC: REVENUE BY BUSINESS SEGMENT 2019–2021 ($ BILLION)
EXHIBIT 82 MEDTRONIC: REVENUE BY GEOGRAPHY 2022 ($ BILLION)
EXHIBIT 83 RESMED: TOTAL REVENUE 2020–2022 ($ BILLION)
EXHIBIT 84 RESMED: R&D EXPENDITURE 2020–2022 ($ BILLION)
EXHIBIT 85 TELADOC HEALTH: TOTAL REVENUE 2020–2022 ($ BILLION)
EXHIBIT 86 TELADOC HEALTH: REVENUE BY GEOGRAPHY 2020–2022 ($ BILLION)
LIST OF TABLES
TABLE 1 KEY CAVEATS
TABLE 2 CURRENCY CONVERSION 2016−2022
TABLE 3 GLOBAL REMOTE PATIENT MONITORING BY GEOGRAPHY 2022–2028 ($ BILLION)
TABLE 4 GLOBAL REMOTE PATIENT MONITORING BY GEOGRAPHY 2022–2028 (%)
TABLE 5 CHRONIC DISEASE PREVALENCE AND IMPACT ON HEALTHCARE SYSTEMS OF US & WORLD
TABLE 6 CHANGE IN HOSPITAL STAY COST IN US 2010–2020
TABLE 7 US REMOTE PATIENT MONITORING MARKET BY COMPONENT: MARKET SIZE 2022 & 2028
TABLE 8 US REMOTE PATIENT MONITORING MARKET BY APPLICATION: MARKET SIZE 2022 & 2028
TABLE 9 US REMOTE PATIENT MONITORING MARKET BY END-USER: MARKET SIZE 2022 & 2028
TABLE 10 FAST FACTS ABOUT US HOSPITALS
TABLE 11 AMD GLOBAL TELEMEDICINE: MAJOR PRODUCT OFFERINGS
TABLE 12 GE HEALTHCARE: MAJOR PRODUCT OFFERINGS
TABLE 13 KONINKLIJKE PHILIPS: MAJOR PRODUCT OFFERINGS
TABLE 14 MEDTRONIC: MAJOR PRODUCT OFFERINGS
TABLE 15 RESMED: MAJOR PRODUCT OFFERINGS
TABLE 16 TELEDOC HEALTH: MAJOR PRODUCT OFFERINGS
TABLE 17 VIVIFY HEALTH: MAJOR PRODUCT OFFERINGS
TABLE 18 100-PLUS: MAJOR PRODUCT OFFERINGS
TABLE 19 ABBOTT: MAJOR PRODUCT OFFERINGS
TABLE 20 ACL DIGITAL: MAJOR PRODUCT OFFERINGS
TABLE 21 ALTUMVIEW: MAJOR PRODUCT OFFERINGS
TABLE 22 BAXTER: MAJOR PRODUCT OFFERINGS
TABLE 23 BIOBEAT: MAJOR PRODUCT OFFERINGS
TABLE 24 BIOFOURMIS: MAJOR PRODUCT OFFERINGS
TABLE 25 BIOTRONIK: MAJOR PRODUCT OFFERINGS
TABLE 26 BOSTON SCIENTIFIC: MAJOR PRODUCT OFFERINGS
TABLE 27 CARDIOLOGS: MAJOR PRODUCT OFFERINGS
TABLE 28 CARDIOMO: MAJOR PRODUCT OFFERINGS
TABLE 29 CAREMINDR: MAJOR PRODUCT OFFERINGS
TABLE 30 CAREVALIDATE: MAJOR PRODUCT OFFERINGS
TABLE 31 CLEARARCH: MAJOR PRODUCT OFFERINGS
TABLE 32 DATOS HEALTH: MAJOR PRODUCT OFFERINGS
TABLE 33 DEXCOM: MAJOR PRODUCT OFFERINGS
TABLE 34 DRÄGERWERK AG: MAJOR PRODUCT OFFERINGS
TABLE 35 F. HOFFMANN-LA ROCHE.: MAJOR PRODUCT OFFERINGS
TABLE 36 GRANDCARE SYSTEMS: MAJOR PRODUCT OFFERINGS
TABLE 37 HEALTH RECOVERY SOLUTIONS: MAJOR PRODUCT OFFERINGS
TABLE 38 HINGE HEALTH: MAJOR PRODUCT OFFERINGS
TABLE 39 HONEYWELL INTERNATIONAL: MAJOR PRODUCT OFFERINGS
TABLE 40 IHEALTH UNIFIED CARE: MAJOR PRODUCT OFFERINGS
TABLE 41 INTEL: MAJOR PRODUCT OFFERINGS
TABLE 42 IRHYTHM TECHNOLOGIES: MAJOR PRODUCT OFFERINGS
TABLE 43 LIMBER HEALTH: MAJOR PRODUCT OFFERINGS
TABLE 44 MASIMO: MAJOR PRODUCT OFFERINGS
TABLE 45 MEDM: MAJOR PRODUCT OFFERINGS
TABLE 46 MEDOPAD.: MAJOR PRODUCT OFFERINGS
TABLE 47 MODIVCARE: MAJOR PRODUCT OFFERINGS
TABLE 48 NIHON KOHDEN: MAJOR PRODUCT OFFERINGS
TABLE 49 OMRON: MAJOR PRODUCT OFFERINGS
TABLE 50 OSI SYSTEMS: MAJOR PRODUCT OFFERINGS
TABLE 51 OSPLABS: MAJOR PRODUCT OFFERINGS
TABLE 52 QARDIO: MAJOR PRODUCT OFFERINGS
TABLE 53 SENSEONICS: MAJOR PRODUCT OFFERINGS
TABLE 54 TELEMEDCARE: MAJOR PRODUCT OFFERINGS
TABLE 55 VENTRICLE HEALTH: MAJOR PRODUCT OFFERINGS
TABLE 56 VITALCONNECT: MAJOR PRODUCT OFFERINGS
TABLE 57 VITLS: MAJOR PRODUCT OFFERINGS
TABLE 58 VIVALNK: MAJOR PRODUCT OFFERINGS
TABLE 59 US REMOTE PATIENT MONITORING MARKET BY COMPONENT 2022−2028 ($ BILLION)
TABLE 60 US REMOTE PATIENT MONITORING MARKET BY COMPONENT 2022−2028 (%)
TABLE 61 US REMOTE PATIENT MONITORING MARKET BY APPLICATION 2022−2028 ($ BILLION)
TABLE 62 US REMOTE PATIENT MONITORING MARKET BY APPLICATION 2022−2028 (%)
TABLE 63 US REMOTE PATIENT MONITORING MARKET BY END-USER 2022−2028 ($ BILLION)
TABLE 64 US REMOTE PATIENT MONITORING MARKET BY END-USER 2022−2028 (%)
TABLE 65 US HOME HEALTHCARE SETTINGS REMOTE PATIENT MONITORING MARKET BY REGION 2022−2028 ($ BILLION)
TABLE 66 US HOME HEALTHCARE SETTINGS REMOTE PATIENT MONITORING MARKET BY REGION 2022−2028 (%)
TABLE 67 US HOME HEALTHCARE REMOTE PATIENT MONITORING MARKET BY COMPONENT 2022−2028 ($ BILLION)
TABLE 68 US HOME HEALTHCARE REMOTE PATIENT MONITORING MARKET BY COMPONENT 2022−2028 (%)
TABLE 69 US HOME HEALTHCARE REMOTE PATIENT MONITORING MARKET BY APPLICATION 2022−2028 ($ BILLION)
TABLE 70 US HOME HEALTHCARE REMOTE PATIENT MONITORING MARKET BY APPLICATION 2022−2028 (%)
Single User Licence
5 User Licence
Corporate Licence
Datasheet Licence
"The report by Arizton was spot on. It not only gave us insight into the pro audio market, we used it to raise funds for our company. The data proved (to the VC we pitched to) that the market was large enough for our company to not only survive but also grow."
